Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Harvard Business School
Julphar
Fuji
Chubb
McKesson
Boehringer Ingelheim
Medtronic

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs with Dosage: PATCH

« Back to Dashboard

Drugs with Dosage: PATCH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Uluru AMLEXANOX amlexanox PATCH;TOPICAL 021727-001 Sep 29, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up PATCH;TOPICAL
Hisamitsu Pharm Co SALONPAS menthol; methyl salicylate PATCH;TOPICAL 022029-002 Nov 5, 2012 OTC Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up PATCH;TOPICAL
Hisamitsu Pharm Co SALONPAS menthol; methyl salicylate PATCH;TOPICAL 022029-002 Nov 5, 2012 OTC Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up PATCH;TOPICAL
Averitas QUTENZA capsaicin PATCH;TOPICAL 022395-001 Nov 16, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up PATCH;TOPICAL
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up PATCH;IONTOPHORESIS, TOPICAL
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up PATCH;IONTOPHORESIS, TOPICAL
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up PATCH;TOPICAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Deloitte
McKesson
Fish and Richardson
Healthtrust
Chinese Patent Office
Citi
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.